image
image
image

Technology Overview

ED Laboratories' lead compounds have been shown to be highly selective for glioblastoma and retinoblastoma tumors. Other Important characteristics of the lead compounds are:

  • They are small molecules having a molecular weights < 500.
  • They appear to be quite stable and are relatively easy to work with.
  • They appear to have a very respectable safety profile.

Glioblastoma
Presentation

Click to view slides showing EDL's lead compound effect on Glioblastoma.

 

 
Other Tumor Types :

Longer term, the company is focused on the development of novel cancer agents for the treatment of other types of tumors.


image